CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy

After one year of absence, the 18th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe’s cancer immunotherapy meeting, took place virtually from 10 to 12 May 2021. Over 850 academic and clinical professionals from 30 countries met to discuss the recent advancements in cancer i...

Descripción completa

Detalles Bibliográficos
Autores principales: Billmeier, Arne, Khinvasara, Krutika, Lang, Franziska, Mohr, Julia, Reidenbach, Daniel, Schork, Maik, Yildiz, Ikra, Diken, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Immunotherapy – Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993083/
https://www.ncbi.nlm.nih.gov/pubmed/35130105
http://dx.doi.org/10.1080/21645515.2021.2024416
_version_ 1784683840982220800
author Billmeier, Arne
Khinvasara, Krutika
Lang, Franziska
Mohr, Julia
Reidenbach, Daniel
Schork, Maik
Yildiz, Ikra
Diken, Mustafa
author_facet Billmeier, Arne
Khinvasara, Krutika
Lang, Franziska
Mohr, Julia
Reidenbach, Daniel
Schork, Maik
Yildiz, Ikra
Diken, Mustafa
author_sort Billmeier, Arne
collection PubMed
description After one year of absence, the 18th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe’s cancer immunotherapy meeting, took place virtually from 10 to 12 May 2021. Over 850 academic and clinical professionals from 30 countries met to discuss the recent advancements in cancer immunotherapy and the current progress in COVID19-related research. This meeting report summarizes the highlights of CIMT2021.
format Online
Article
Text
id pubmed-8993083
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-89930832022-04-09 CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy Billmeier, Arne Khinvasara, Krutika Lang, Franziska Mohr, Julia Reidenbach, Daniel Schork, Maik Yildiz, Ikra Diken, Mustafa Hum Vaccin Immunother Immunotherapy – Meeting Report After one year of absence, the 18th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe’s cancer immunotherapy meeting, took place virtually from 10 to 12 May 2021. Over 850 academic and clinical professionals from 30 countries met to discuss the recent advancements in cancer immunotherapy and the current progress in COVID19-related research. This meeting report summarizes the highlights of CIMT2021. Taylor & Francis 2022-02-07 /pmc/articles/PMC8993083/ /pubmed/35130105 http://dx.doi.org/10.1080/21645515.2021.2024416 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Immunotherapy – Meeting Report
Billmeier, Arne
Khinvasara, Krutika
Lang, Franziska
Mohr, Julia
Reidenbach, Daniel
Schork, Maik
Yildiz, Ikra
Diken, Mustafa
CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy
title CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy
title_full CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy
title_fullStr CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy
title_full_unstemmed CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy
title_short CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy
title_sort cimt 2021: report on the 18th annual meeting of the association for cancer immunotherapy
topic Immunotherapy – Meeting Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993083/
https://www.ncbi.nlm.nih.gov/pubmed/35130105
http://dx.doi.org/10.1080/21645515.2021.2024416
work_keys_str_mv AT billmeierarne cimt2021reportonthe18thannualmeetingoftheassociationforcancerimmunotherapy
AT khinvasarakrutika cimt2021reportonthe18thannualmeetingoftheassociationforcancerimmunotherapy
AT langfranziska cimt2021reportonthe18thannualmeetingoftheassociationforcancerimmunotherapy
AT mohrjulia cimt2021reportonthe18thannualmeetingoftheassociationforcancerimmunotherapy
AT reidenbachdaniel cimt2021reportonthe18thannualmeetingoftheassociationforcancerimmunotherapy
AT schorkmaik cimt2021reportonthe18thannualmeetingoftheassociationforcancerimmunotherapy
AT yildizikra cimt2021reportonthe18thannualmeetingoftheassociationforcancerimmunotherapy
AT dikenmustafa cimt2021reportonthe18thannualmeetingoftheassociationforcancerimmunotherapy

Ejemplares similares